公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2007 | Gemcitabine Is Preferentially Chemosensitive in Cyclin D1 or Cyclin E over-Expressing Human Gastric Cancer Cells | SHEN, YING-CHUN; CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2013 | Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression (vol 15, pg 265, 2012) | Hsu, Chiun; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Yeh, Kun-Huei; 鄭安理 | Gastric Cancer | | | |
2014 | High serum transforming growth factor beta 1 levels associated with poor survivals in patients with advanced hepatocellular carcinoma | Lin, Tzu-Hsuan; Shao, Yu-Yun; Chan, Soa-Yu; Huang, Chung-Yi; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; 鄭安理 | Cancer | | | |
2012 | HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA | Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 鄭安理; 徐志宏 | Ann. Oncol. | | | |
1988 | HTLV-I-Associated Lymphoma/Leukemia As Secondary Maligenancy in Patients with Hematological Neoplasms | 陳耀昌; 王秋華; Su, Ih-Jen; 鄭安理; Chou, Min-Ji; Essex, Myron; 楊照雄; 陳宜君; Wang, Chiu-Hwa; Chen, Yee-Chun | Experimental Hematology | | | |
2005 | Identification and Characterization of a Novel Gene Saf Transcribed from the Opposite Strand of Fas | YAN, MING-DE; LAI, GI-MING; CHENG, ANN- LII; LIN, YA-WEN; CHUANG, SHUANG-EN; 鄭安理 | HUMAN MOLECULAR GENETICS | | | |
2009 | Impact of Lung and Lymph Node Metastasis on Efficacy and Safety Following Treatment with Sorafenib in Patients with Hepatocellular Carcinoma from the Asia-Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2009 | Impact of Prior Surgical Resection with Curative Intent on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc): Subset Analysis of the Asia-Pacific (Ap) Study | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | JOURNAL OF CLINICAL ONCOLOGY | | | |
2009 | Impact of Prior Tace/Tae on the Efficacy and Safety of Sorafenib in Patients with Advanced Hepatocellular Carcinoma (Hcc) from the Asia- Pacific Region | CHENG, ANN-LII; 鄭安理 | JOURNAL OF HEPATOLOGY | | | |
2002 | Increase of the Resistance of Human Cervical Carcinoma Cells to Cisplatin by Inhibition of the Mek to Erk Signaling Pathway Partly Via Enhancement of Anticancer Drug-Induced Nf Kappa B Activation | CHENG, ANN-LII; 鄭安理 | BIOCHEMICAL PHARMACOLOGY | | | |
2014 | Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2004 | Interleukin-6 Is Responsible for Drug Resistance and Anti-Apoptotic Effects in Prostatic Cancer Cells | PU, YEONG-SHIAU; HOUR, TZYH-CHYUAN; CHUANG, SHUANG-EN; CHENG, ANN-LII; LAI, MING-KUEN; KUO, MIN-LIANG; 鄭安理 | PROSTATE | | | |
2016 | Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration | Shao, Y-Y.; Chen, B-B.; Lin, Z-Z.; Hsu, C-H.; Wang, M-J.; Cheng, A-L.; Hsu, C.; 邵幼雲; 鄭安理; 陳邦斌; 徐志宏 | Annals of Oncology | 0 | 1 | |
1987 | Lineage Specific Classification of Adult Acute Lymphoblastic Leukemia:Analysis of 30 Cases | Cheng, Ann-Lii; Chen, Yee-Chun; 鄭安理 | Journal of the Formosan Medical Association | | | |
2015 | LONG-TERM OUTCOME OF CHEMOTHERAPY-INDUCED HBV REACTIVATION IN LYMPHOMA PATIENTS WITH RESOLVED HBV INFECTION | Yang, H. -C.; Tsou, H. -H.; Chuang, M. -H.; Chen, C. -L.; Liu, T. -W.; Chen, P. -J.; Cheng, A. -L.; Hsu, C.; 鄭安理; 陳培哲; 陳祈玲 | J. Hepatol. | | | |
2005 | Long-Term Results of Anti–Helicobacter Pylori Therapy in Early-Stage Gastric High-Grade Transformed Malt Lymphoma | CHENG, ANN-LII; WHANG-PENG, JACQUELINE; SU, IH-JEN; JAN, CHANG-MING; SHEU, BOR-SHYANG; KUO, SUNG-HSIN; WANG, HSIU-PO; CHEN, GRAN-HUM; TAI, JOHN JEN; LIN, JAW-TOWN; CHEN, LI-TZONG; 鄭安理 | JOURNAL OF THE NATIONAL CANCER INSTITUTE | | | |
2012 | LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA | Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 謝明書 | Ann. Oncol. | | | |
1998 | Megestrol Acetate Antagonizes Cisplatin Cytotoxicity | PU, YEONG-SHIAU; CHENG, ANN-LII; CHEN, JUN; GUAN, JING-YI; LIU, SHIO-HUEI; LAI, MING-KUEN; HSIEH, CHANG-YAO; 鄭安理 | ANTICANCER RESEARCH | | | |
1991 | Menadione-Induced DNA Damage in a Human Tumor Cell Line | Sun, T. P.; Chang, J. Y.; Wang, C. C.; Cheng, Ann-Lii; Nutter, L. M.; Ngo, E. O.; Chi, K. H.; 鄭安理 | Biochemical Pharmacology | | | |